Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glibenclamide Effect on Glucagon Response in Type 1 Diabetes
NCT00515801Phase 3Completed
- Sponsor
- University Hospital Basel
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of glibenclamide in type 1 diabetes mellitus (T1D), sponsored by University Hospital Basel. Started Jun 2007; status: completed.
02
Drugs
glibenclamide
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00515801.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00515801.